STUDY ON THE PREVALENCE OF DYSLIPIDEMIA AND SOME RELATED FACTORS IN PATIENTS WITH PSORIASIS

Tiến Thành Trịnh , Kim Sơn Trần, Phương Quyên Trần, Thị Vân Bùi

Main Article Content

Abstract

Introduction: Psoriasis is a multi-system disorder involving inflammatory responses, and its treatment can trigger lipid metabolism disorders. However, studies on this issue in Vietnam are still limited. Objective: To investigate the prevalence of dyslipidemia and its related factors in patients with psoriasis.  Methods: A cross-sectional descriptive study was conducted on psoriasis patients visiting Can Tho Dermatology Hospital and the FOB International Dermatology and Aesthetic Research Institute from June 2022 to May 2024. Results: A total of 80 patients were included, with 47.5% being male. Male patients had higher levels of total cholesterol and LDL cholesterol than females. The overall prevalence of dyslipidemia was 62.5%. Dyslipidemia was more common in males than females, with rates of 73.7% and 52.4%, respectively. Alcohol consumption and early disease onset (before 30 years of age) were associated with dyslipidemia. Conclusion: Psoriasis patients have a relatively high prevalence of dyslipidemia. Alcohol consumption is a risk factor for dyslipidemia, while early disease onset appears to be a protective factor.

Article Details

References

1. Parisi R, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. Journal of Investigative Dermatology. 2013. 133(2), p. 377-385.
2. Mirza UA, et al. Association of dyslipidemia with psoriasis. Journal of Pakistan Association of Dermatologists. 2018. 28(4), p. 532-539.
3. Miao C, et al. Obesity and dyslipidemia in patients with psoriasis: A case–control study. Medicine. 2019. 98(31), p. e16323.
4. Salihbegovic EM, et al. Psoriasis and dyslipidemia. Materia sociomedica. 2015. 27(1), p. 15.
5. Bộ Y Tế. Hướng dẫn chẩn đoán và điều trị các bệnh da liễu. Quyết định số 75/QĐ-BYT ngày 13 tháng 01 năm 2015, tr. 161-166.
6. Lym YL, et al. Prevalence and Risk Factors of the Metabolic Syndrome as Defined by NCEP-ATP III. Journal of the Korean Academy of Family Medicine. 2003. 24(2), p. 135-143.
7. Ghafoor R, et al. Dyslipidemia and psoriasis: a case control study. J Coll Physicians Surg Pak. 2015. 25(5), p. 324-7.
8. Steiner JL, et al. Adipose tissue and lipid dysregulation. Biomolecules. 2017. 7(1), p. 16.